⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AMGN News
Amgen Inc
Zoomex Launches TradFi Zone Upgrade With 80% Fee Discount Early Bird Campaign
globenewswire.com
AAPL
MSFT
GOOGL
AMZN
META
TSLA
NVDA
AMD
INTC
AVGO
ASML
ARM
MRVL
QCOM
TXN
COIN
MSTR
MARA
RIOT
CIFR
HOOD
UNH
GE
JPM
GILD
AMGN
REGN
WMT
KO
PEP
MA
PYPL
BRK.B
Global CD70-Targeting Therapies Market Report 2026 - Highlights Clinical Innovation, Pipeline Trends and Commercial Opportunities
globenewswire.com
ALLO
CRSP
JNJ
PFE
ADCT
REGN
MRNA
BMY
GILD
AMGN
BIIB
AZN
NVS
LLY
ABBV
Global KIF18A Targeting Therapies Market Insights Report 2026: Profiles Volastra, Accent, Insilico, Amgen, Aurigene, Tailor Bio and Other Key Players
globenewswire.com
AMGN
VTRS
ACNT
TEZSPIRE® DEMONSTRATES POSITIVE PHASE 3 RESULTS IN EOSINOPHILIC ESOPHAGITIS ACROSS BOTH CO-PRIMARY AND ALL KEY SECONDARY ENDPOINTS
prnewswire.com
AMGN
Oncolytic Virus Cancer Therapy Market Expected to Expand Rapidly During the Forecast Period (2026-2036) Amid Rising Investments in Next-Generation Cancer Treatments| DelveInsight
prnewswire.com
AMGN
CGON
CLNN
RPRX
BTAI
ONCY
Workato Launches Otto for Everyone, AI Superagents That Run Whole Projects Start to Finish
businesswire.com
AMZN
CSCO
NVDA
GOOG
MSFT
IBM
ORCL
CRM
INTC
AMD
MU
QCOM
AAPL
META
NFLX
GOOGL
AMPL
SPCE
TSLA
BNTX
CRSP
EDIT
GILD
MRNA
REGN
VRTX
BIIB
AMGN
NCLH
CCL
RCL
XOM
CVX
SHEL
T
VZ
TMUS
NKE
DIS
MCD
KO
PEP
WMT
HD
JNJ
PG
UNH
MA
V
BOX
SHOP
Blood Cancer Therapeutics Market to Reach $125.5 Billion by 2030, Driven by Precision Medicine Advances and Expanding Immunotherapy Pipelines
globenewswire.com
ABBV
AMGN
AZN
BMY
ROG
GILD
GSK
JNJ
LLY
MRK
NVS
SNY
PFE
JAZZ
AMRX
Concordare Trials Secures Funding Round to Accelerate Digitization of Clinical Trial Protocols
businesswire.com
AMGN
JNJ
VEEV
AI Poised to Reshape Blood Cancer Therapeutics as Investment Surges Past $2 Billion Across Leading Biotech and Pharma Players
globenewswire.com
SNY
MRK
BMY
AZN
AMGN
PFE
GENK
QURE
ABSI
NVDA
State of the Life Sciences Industry to Be Reviewed in BCC Research's 2026 Second Quarter Outlook, Spotlighting AI-Driven Discovery, Precision Oncology, and Connected Health Adoption
globenewswire.com
TEVA
AZN
GSK
NVS
PFE
JNJ
BMY
MRK
LLY
REGN
ILMN
CHTR
EVO
AMGN
ABT
GH